Last updated on July 2019

Study to Patients With Stable COPD to Assess the Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate (DUAKLIR)


Brief description of study

This is a multiple dose, randomised, parallel, double blind, double dummy, multicentre and multinational Phase III study to determine the efficacy and safety of Aclidinium bromide/Formoterol fumarate compared with individual components and placebo and Aclidinium bromide compared with Placebo when administered to patients with stable Chronic Obstructive Pulmonary Disease (COPD).

Clinical Study Identifier: NCT03022097

Find a site near you

Start Over

Research Site

Changchun, China
  Connect »

Research Site

Chongqing, China
  Connect »

Research Site

Guangzhou, China
  Connect »

Research Site

Shengyang, China
  Connect »

Research Site

Shijiazhuang, China
  Connect »

Research Site

Zhanjiang, China
  Connect »

Research Site

Ahmedabad, India
  Connect »

Research Site

Alappuzha, India
  Connect »

Research Site

Bangalore, India
  Connect »

Research Site

Ernakulam District, India
  Connect »

Research Site

Kozhikode, India
  Connect »

Research Site

Vijayawada, India
  Connect »

Research Site

Vijaywada, India
  Connect »

Research Site

Caloocan City, Philippines
  Connect »

Research Site

Iloilo City, Philippines
  Connect »

Research Site

Manila, Philippines
  Connect »

Research Site

Quezon City, Philippines
  Connect »

Research Site

Taichung City, Taiwan
  Connect »

Research Site

Taichung, Taiwan
  Connect »

Research Site

Ho Chi Minh City, Vietnam
  Connect »

Research Site

Ho Chi Minh, Vietnam
  Connect »

Research Site

Liangyugang, China
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.